BenzingaOctober 21, 2026 at 8:55 AM NY6 Days Ago
Morgan Stanley Maintains Overweight on Vistra, Lowers Price Target to $226
Morgan Stanley analyst Stephen Byrd maintains Vistra (NYSE:VST) with a Overweight and lowers the price target from $227 to $226.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga